Clinical Trials

NCT04924075 | RECRUITING | PHASE2
355 participants

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2021-08-12
Completion:
2029-12-27
Conditions
  • Pheochromocytoma/Paraganglioma
  • Pancreatic Neuroendocrine Tumor
  • Von Hippel-Lindau Disease
  • Advanced Gastrointestinal Stromal Tumor
  • HIF-2α Mutated Cancers
Interventions
  • DRUG
No Results Yet
NCT04876781 | RECRUITING
200 participants

Korean Post-marketing Surveillance for Xeljanz XR

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-03
Start Date:
2022-01-12
Completion:
2026-09-22
Conditions
  • Active Moderate to Severe Rheumatoid Arthritis
  • Active Ankylosing Spondylitis
  • Active Psoriatic Arthritis
Interventions
  • DRUG
No Results Yet
NCT04753970 | RECRUITING | PHASE1/PHASE2
100 participants

Retina is a Marker for Cerebrovascular Heath

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2021-02-09
Completion:
2030-06-30
Conditions
  • Cerebral Small Vessel Diseases
  • Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy
  • Cerebral Microbleeding
  • Sporadic White Matter Disease
Interventions
  • DRUG
No Results Yet
NCT04512287 | COMPLETED | PHASE2
65 participants

PRP for Treatment of Peyronie's Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2021-03-29
Completion:
2025-08-11
Conditions
  • Peyronie Disease
  • Sexual Dysfunction, Physiological
  • Sexual Dysfunction Male
  • Genital Diseases, Male
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page